[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FI762433A - - Google Patents

Info

Publication number
FI762433A
FI762433A FI762433A FI762433A FI762433A FI 762433 A FI762433 A FI 762433A FI 762433 A FI762433 A FI 762433A FI 762433 A FI762433 A FI 762433A FI 762433 A FI762433 A FI 762433A
Authority
FI
Finland
Application number
FI762433A
Other languages
Finnish (fi)
Inventor
Motoyoshi Kajihara
Toshihiro Hamakawa
Toshiaki Shibata
Takashi Suzue
Setsuro Fujii
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Publication of FI762433A publication Critical patent/FI762433A/fi

Links

Classifications

    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F22STEAM GENERATION
    • F22BMETHODS OF STEAM GENERATION; STEAM BOILERS
    • F22B1/00Methods of steam generation characterised by form of heating method
    • F22B1/02Methods of steam generation characterised by form of heating method by exploitation of the heat content of hot heat carriers
    • F22B1/18Methods of steam generation characterised by form of heating method by exploitation of the heat content of hot heat carriers the heat carrier being a hot gas, e.g. waste gas such as exhaust gas of internal-combustion engines
    • F22B1/1884Hot gas heating tube boilers with one or more heating tubes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/785Polymers containing nitrogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/795Polymers containing sulfur
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S165/00Heat exchange
    • Y10S165/355Heat exchange having separate flow passage for two distinct fluids
    • Y10S165/40Shell enclosed conduit assembly
    • Y10S165/401Shell enclosed conduit assembly including tube support or shell-side flow director
    • Y10S165/405Extending in a longitudinal direction

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Thermal Sciences (AREA)
  • Sustainable Energy (AREA)
  • Sustainable Development (AREA)
  • Combustion & Propulsion (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FI762433A 1975-08-26 1976-08-24 FI762433A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB35250/75A GB1506217A (en) 1975-08-26 1975-08-26 Oral antilipemic composition

Publications (1)

Publication Number Publication Date
FI762433A true FI762433A (de) 1977-02-27

Family

ID=10375590

Family Applications (1)

Application Number Title Priority Date Filing Date
FI762433A FI762433A (de) 1975-08-26 1976-08-24

Country Status (9)

Country Link
US (1) US4232007A (de)
JP (1) JPS5228947A (de)
AU (2) AU504099B2 (de)
BE (1) BE845518A (de)
CA (1) CA1065253A (de)
FI (1) FI762433A (de)
FR (1) FR2321898A1 (de)
GB (1) GB1506217A (de)
NL (1) NL166400C (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59175589U (ja) * 1983-05-12 1984-11-24 鹿浜工業株式会社 竪枠構造
CS252559B1 (en) * 1985-03-22 1987-09-17 Frantisek Rypacek Polymer stabilizer of emulsion type water in oil
US5721221A (en) * 1991-03-08 1998-02-24 Regents Of The University Of Minnesota Lowering blood cholesterol levels using water soluble cellulose ethers
US5705178A (en) * 1991-05-31 1998-01-06 Gliatech, Inc. Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers
US5605938A (en) * 1991-05-31 1997-02-25 Gliatech, Inc. Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate
EP0548794B1 (de) * 1991-12-20 1999-06-09 Hoechst Aktiengesellschaft Polyaspartamidderivate als Adsorptionsmittel für Gallensäuren, mit Gallensäuren beladene Polyaspartamidderivate und Verfahren zu deren Herstellung sowie deren Anwendung als Arzneimittel
US8084424B2 (en) 2003-04-09 2011-12-27 University Of Utah Research Foundation Compositions and methods related to erythropoietin
EP1685845A4 (de) * 2003-11-19 2009-02-11 Meiji Seika Kaisha Sialogogu und dieses enthaltende orale zusammensetzung und nahrungszusammensetzung
EP2455089B1 (de) 2009-07-16 2016-05-18 Kao Corporation Hemmer der erhöhung des gip-spiegels im blut
JP5498073B2 (ja) * 2009-07-16 2014-05-21 花王株式会社 血中トリグリセリド濃度上昇抑制剤
JP2011037843A (ja) * 2009-07-16 2011-02-24 Kao Corp 食後血中インスリン濃度上昇抑制剤
JP2011046647A (ja) * 2009-08-27 2011-03-10 Ajinomoto Co Inc ポリ−γ−グルタミン酸を含有するコレステロール抑制剤
JP2012144487A (ja) * 2011-01-12 2012-08-02 Kao Corp 血中トリグリセリド濃度上昇抑制剤
JP2012144484A (ja) * 2011-01-12 2012-08-02 Kao Corp 血中トリグリセリド濃度上昇抑制剤
US9056066B2 (en) 2011-01-12 2015-06-16 Kao Corporation Agent for suppressing elevation of blood GIP level, agent for suppressing elevation of blood insulin level, agent for lowering blood triglyceride level after meal ingestion, and agent for suppressing elevation of blood glucose level

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK113339B (da) * 1963-07-30 1969-03-10 Kyowa Hakko Kogyo Kk Foderstof.
US3503951A (en) * 1965-06-15 1970-03-31 Ciba Geigy Corp Complexes of a.c.t.h. peptides with polyglutamic and polyaspartic acid
US3849554A (en) * 1965-12-01 1974-11-19 Nasa Reduction of blood serum cholesterol

Also Published As

Publication number Publication date
AU1714676A (en) 1978-03-02
NL166400B (nl) 1981-03-16
FR2321898B1 (de) 1980-02-01
AU1584376A (en) 1978-01-19
AU504099B2 (en) 1979-10-04
GB1506217A (en) 1978-04-05
US4232007A (en) 1980-11-04
AU499744B2 (en) 1979-05-03
JPS5616776B2 (de) 1981-04-18
CA1065253A (en) 1979-10-30
NL166400C (nl) 1981-08-17
NL7609463A (nl) 1977-03-01
BE845518A (fr) 1976-12-16
JPS5228947A (en) 1977-03-04
FR2321898A1 (fr) 1977-03-25

Similar Documents

Publication Publication Date Title
FR2321898B1 (de)
JPS5754863B2 (de)
JPS537536B2 (de)
JPS51103383U (de)
JPS51158313U (de)
JPS5735988Y2 (de)
AU489798B2 (de)
JPS5244643Y2 (de)
JPS51163991U (de)
JPS5227576U (de)
JPS5237732U (de)
JPS5226575U (de)
JPS5189859U (de)
JPS51102549A (de)
BG22168A1 (de)
CH600132A5 (de)
BG22154A1 (de)
CH591588A5 (de)
BG22192A1 (de)
BG22194A1 (de)
BG22609A1 (de)
BG23094A1 (de)
CH4975A4 (de)
CH580878A5 (de)
CH536275A4 (de)

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: TAIHO PHARMACEUTICAL COMPANY, LIMITED